Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel approaches to advanced breast cancer: bevacizumab and lapatinib.

Novel approaches to advanced breast cancer: bevacizumab and lapatinib. J Natl Compr Canc Netw. 2007 Mar; 5(3):314-23.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.